Immediate Impact
5 from Science/Nature 50 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of Xumei Li being referenced
Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis
2020
PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin‑3‑gallate in ovarian cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Xumei Li | 387 | 20 | 109 | 273 | 185 | 20 | 836 | |
| Santanu Raychaudhuri | 499 | 13 | 55 | 178 | 72 | 19 | 961 | |
| Xin‐Ying Tang | 292 | 65 | 100 | 66 | 50 | 40 | 868 | |
| Soyoung Shin | 416 | 32 | 48 | 269 | 126 | 45 | 837 | |
| Wen Xiong | 306 | 23 | 44 | 91 | 69 | 48 | 860 | |
| Nina M. Pollak | 478 | 22 | 46 | 107 | 220 | 25 | 851 | |
| S Itagaki | 453 | 31 | 104 | 91 | 133 | 37 | 906 | |
| Judith Hasler‐Rapacz | 296 | 52 | 92 | 142 | 40 | 33 | 834 | |
| Annika Lundqvist | 499 | 37 | 77 | 79 | 239 | 32 | 877 | |
| Joe L. Rowles | 267 | 43 | 98 | 27 | 135 | 20 | 818 | |
| Paul Cheung | 367 | 24 | 73 | 312 | 49 | 20 | 846 |
All Works
Login with ORCID to disown or claim papers
Loading papers...